The Federal Government has directed the National Agency for Food and Drug Administration and Control (NAFDAC) to suspend enforcement of its proposed ban on sachet-packaged alcoholic beverages, citing concerns over potential economic disruption and the need for broader consultations before a final policy decision is reached.
The directive, issued through the Office of the Secretary to the Government of the Federation (OSGF), places all enforcement actions relating to the proposed ban on hold pending further review and stakeholder engagement.
Policy Review Underway
The move follows concerns raised by members of the National Assembly and industry stakeholders regarding the possible impact of the ban on employment, small-scale distributors, manufacturers, and the wider beverage value chain.
The sachet alcohol restriction had been proposed as part of efforts to address public health concerns, particularly underage drinking and the easy accessibility of small, affordable alcoholic products. The planned enforcement timeline had drawn significant attention nationwide.
However, critics argued that an abrupt implementation could lead to widespread job losses, business closures, and broader economic strain, especially among small traders and logistics operators who rely heavily on sachet products for income.
Balancing Public Health and Economic Stability
Government officials indicated that the suspension is intended to allow for a more consultative and balanced approach, ensuring that public health objectives are pursued without triggering unintended economic consequences.
Labour unions, manufacturers’ associations, and employer groups had previously called for a review of the ban, urging authorities to consider phased implementation or alternative regulatory measures.
Next Steps
With enforcement now suspended, the Federal Government is expected to engage relevant stakeholders to develop a revised framework that addresses concerns around alcohol abuse while safeguarding jobs, investments, and economic stability.
NAFDAC, as the country’s primary regulatory agency for food and drug safety, will await further directive as consultations continue.
